Comparing two surgical methods for left colon cancer treatment
Application of Overlap Method to Digestive Tract Reconstruction of Totally Laparoscopic Left Colectomy
This study is trying to see which of two different surgical methods works better for treating left colon cancer in patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Tang-Du Hospital Academic / other |
| Locations | 1 site (Xian, Shan XI Province) |
| Trial ID | NCT05034692 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to compare the outcomes of total laparoscopic colectomy with intracorporeal anastomosis using the overlap method against laparoscopic-assisted colectomy with extracorporeal anastomosis for patients with left colon cancer. The study is a randomized, single-center, single-blind controlled trial where patients will be assigned to either the experimental or control group. Key metrics such as perioperative recovery, complications, and oncology indices will be analyzed to determine the effectiveness of each surgical approach.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 75 with a BMI between 18 and 30 and specific staging of colon neoplasm.
Not a fit: Patients outside the age range of 18 to 75, those with a BMI below 18 or above 30, or those with advanced neoplasm staging may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved surgical outcomes and recovery for patients undergoing surgery for left colon cancer.
How similar studies have performed: While this approach is being tested in this trial, similar studies have shown promise in improving surgical techniques for colon cancer.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ASA\<3 classification * 18kg/m2≤BMI≤30kg/m2 * Neoplasm staging is T1-4a, N0-2, M0 * No previous history of abdominal surgery * No previous history of neoplasm chemoradiotherapy * No status of ileus, bowel obstruction and active hemorrhage of the digestive tract Exclusion Criteria: * Age\<18 years or \>75 years * ASA≥3 classification * BMI\<18kg/m2 or BMI\>30kg/m2 * Neoplasm staging is T4b or M1 Underwent chemoradiotherapy Appeared status of ileus,bowel perforation or active hemorrhage of digestive tract Patients with pregnant
Where this trial is running
Xian, Shan XI Province
- General Surgery Gastrointestinal Department，Tang-Du of Fourth Military Medical University — Xian, Shan XI Province, China (Recruiting)
Study contacts
- Study coordinator: Nan Wang, Doctor
- Email: wangnandoc@163.com
- Phone: 0086-029-84778829
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.